Ultromics

Ultromics is a leading developer of artificial intelligence (AI) solutions for echocardiography, focused on improving heart failure detection. Their flagship product, EchoGo Heart Failure, utilizes AI to analyze echocardiogram images, providing healthcare professionals with precise and timely diagnoses. This platform can detect heart failure with preserved ejection fraction (HFpEF), a complex condition that often goes undiagnosed, with 90% accuracy. EchoGo Heart Failure is FDA-cleared, CE-marked, and reimbursable in both inpatient and outpatient settings.

Ultromics is committed to collaboration and has partnered with world-renowned institutions like the Mayo Clinic, the Foundation for the National Institutes of Health (FNIH), and Johnson & Johnson Innovative Medicine. Their innovative technology has earned multiple awards, including the NHSx AI in Health and Care Award and FDA Breakthrough Device Designation for their AI-enhanced platform for detecting HFpEF and cardiac amyloidosis. Ultromics' vision is to transform heart disease detection, leading to better patient outcomes and a significant reduction in healthcare costs.

Ultromics offers flexible work arrangements for its employees, including flexible working hours and the option to work remotely. The company encourages a healthy work-life balance, providing employees with a generous amount of paid time off, company-wide events and a personal learning budget.

Ultromics offers a comprehensive benefits package that includes a bonus scheme, flexible working hours and remote work options, health, life and dental insurance, private medical insurance, fitness cash back incentive, a cycle scheme, a 5% company pension contribution, paid holiday with additional paid company holidays in December, an employee referral reward, a personal learning budget, and company-wide events.

Ultromics is a global technology company dedicated to improving outcomes for patients with heart failure by leveraging artificial intelligence (AI) to enhance echocardiography. Their mission is to make heart failure detection easier for providers and prognosis better for patients, minimizing the added risks and costs of untreated individuals. They strive to deliver precise, efficient, and fast diagnoses for patients by connecting healthcare settings with a service for interpreting echocardiogram scans.

Ultromics fosters a culture that values compassion, creativity, courage, and connection. They prioritize open communication, diverse perspectives, and a supportive environment where individuals are encouraged to embrace challenges, question the status quo, and contribute to a positive and impactful culture. Their commitment to teamwork extends beyond internal collaboration, encompassing partnerships with healthcare professionals, patients, and partners to stay ahead of the curve and drive meaningful change in the field of echocardiography.

Ultromics is committed to fostering a diverse, equitable, and inclusive workplace. They strive to create an environment where everyone feels valued, respected, and empowered to contribute their unique talents and perspectives. This is reflected in their company values, which emphasize compassion, creativity, courage, and connection. They believe that a diverse workforce leads to better decision-making, innovation, and ultimately, a more positive impact on the lives of their customers and the communities they serve.